Boston Advisors’s Veracyte VCYT Stock Holding History

Boston Advisors’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$1.3M	Buy	54,066 +28,812	+114%	+$766K	0.07%	346
2019 Q2	$720K	Buy	+25,254	New	+$631K	0.04%	421
2018 Q1	–	Sell	-60,800	Closed	-$397K	–	672
2017 Q4	$397K	Buy	60,800 +1,890	+3%	+$14.1K	0.01%	541
2017 Q3	$517K	Buy	58,910 +11,620	+25%	+$94.5K	0.01%	490
2017 Q2	$394K	Sell	47,290 -1,155	-2%	-$9.42K	0.01%	534
2017 Q1	$445K	Buy	+48,445	New	+$396K	0.01%	492
2015 Q3	–	Sell	-32,975	Closed	-$367K	–	786
2015 Q2	$367K	Buy	+32,975	New	+$325K	0.02%	560

Other funds holding VCYT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Boston Advisors's VCYT Position: Q3 2019 in Review

Boston Advisors increased its Veracyte (VCYT) stake by 114% in Q3 2019, buying an estimated $766K and bringing the position to 54,066 shares worth $1.3M. The position accounts for 0.07% of the portfolio, ranked #346.

Boston Advisors first reported a position in VCYT in Q2 2015 and has held it in 7 quarters since. 187 funds tracked by Wall St. Rank hold VCYT as of Q3 2019.

Boston Advisors held 54,066 shares of Veracyte worth $1.3M as of Q3 2019.
Boston Advisors bought 28,812 Veracyte shares in Q3 2019, an estimated $766K.
Veracyte made up 0.07% of Boston Advisors's portfolio in Q3 2019, its #346 holding.
Boston Advisors first reported a position in Veracyte in Q2 2015 and has held it in 7 quarters since.
187 funds tracked by Wall St. Rank held Veracyte as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.